Changes in central corneal thickness over time: the ocular hypertension treatment study.

Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study. Ophthalmology (2013) 2.29

Comparison of ocular response analyzer parameters in primary open angle glaucoma and exfoliative glaucoma patients. Indian J Ophthalmol (2014) 1.54

Central corneal thickness measurements in premature infants. Int J Ophthalmol (2014) 0.86

Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol (2011) 0.85

Relationship of change in central corneal thickness to visual field progression in eyes with glaucoma. Graefes Arch Clin Exp Ophthalmol (2013) 0.84

The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Am J Ophthalmol (2013) 0.79

Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues. Indian J Ophthalmol (2015) 0.78

Switching efficacy on intraocular pressure from latanoprost to bimatoprost in eyes with open angle glaucoma: implication to the changes of central corneal thickness. Jpn J Ophthalmol (2014) 0.77

Intraocular pressure profile during the modified diurnal tension curve using Goldman applanation tonometry and dynamic contour tonometry. J Ocul Biol Dis Infor (2009) 0.75

Long-term change in central corneal thickness from a glaucoma perspective. Indian J Ophthalmol (2013) 0.75

Association of POAG risk factors and the Thr377Met MYOC mutation in an isolated Greek population. Invest Ophthalmol Vis Sci (2010) 0.75

Comparison of dynamic contour tonometry and Goldmann applanation tonometry in relation to central corneal thickness in primary congenital glaucoma. Graefes Arch Clin Exp Ophthalmol (2012) 0.75

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38

Anterior chamber depth, iridocorneal angle width, and intraocular pressure changes after phacoemulsification: narrow vs open iridocorneal angles. Arch Ophthalmol (2011) 2.64

Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol (2004) 2.39

Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology (2012) 2.35

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology (2006) 2.28

Ethnic differences in intraocular pressure reduction and changes in anterior segment biometric parameters following cataract surgery by phacoemulsification. Clin Experiment Ophthalmol (2012) 2.26

Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14

Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology (2008) 2.05

The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol (2004) 2.03

Quality of life in keratoconus. Am J Ophthalmol (2004) 2.03

Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology (2007) 2.00

Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol (2005) 1.80

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol (2006) 1.80

Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol (2003) 1.76

Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol (2007) 1.62

The utility of the monocular trial: data from the ocular hypertension treatment study. Ophthalmology (2010) 1.61

Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology (2011) 1.58

Importance of vitreous liquefaction in age-related cataract. Invest Ophthalmol Vis Sci (2004) 1.56

The association between glaucoma prevalence and supplementation with the oxidants calcium and iron. Invest Ophthalmol Vis Sci (2012) 1.50

Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol (2004) 1.49

Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology (2011) 1.47

Baseline visual field characteristics in the ocular hypertension treatment study. Ophthalmology (2002) 1.46

Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.44

Is a history of diabetes mellitus protective against developing primary open-angle glaucoma? Arch Ophthalmol (2008) 1.43

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood (2011) 1.37

The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center. Am J Ophthalmol (2002) 1.27

Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma. Ophthalmology (2011) 1.23

Resident-performed Ex-PRESS shunt implantation versus trabeculectomy. J Glaucoma (2012) 1.21

Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders. Am J Ophthalmol (2005) 1.20

Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol (2008) 1.18

Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol (2010) 1.18

Longitudinal changes in visual acuity in keratoconus. Invest Ophthalmol Vis Sci (2006) 1.18

The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.16

Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol (2011) 1.14

Reproducibility of scleral spur identification and angle measurements using fourier domain anterior segment optical coherence tomography. J Ophthalmol (2012) 1.14

Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea (2006) 1.11

Intraocular pressure and ocular pulse amplitude comparisons in different types of glaucoma using dynamic contour tonometry. Curr Eye Res (2006) 1.10

Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology (2011) 1.08

Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology (2007) 1.07

Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study. Ophthalmology (2009) 1.06

The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol (2004) 1.06

Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study. Ophthalmology (2010) 1.05

Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol (2006) 1.05

Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci (2012) 1.03

The lifetime economic burden of keratoconus: a decision analysis using a markov model. Am J Ophthalmol (2011) 1.01

Association of biometric factors with anterior chamber angle widening and intraocular pressure reduction after uneventful phacoemulsification for cataract. J Cataract Refract Surg (2011) 1.01

Comparison of different modes in optical coherence tomography and ultrasound biomicroscopy in anterior chamber angle assessment. J Glaucoma (2009) 0.99

The rate of visual field change in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2012) 0.98

The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology (2007) 0.98

Visual field quality control in the Ocular Hypertension Treatment Study (OHTS). J Glaucoma (2007) 0.97

Dynamic contour tonometry: principle and use. Clin Experiment Ophthalmol (2006) 0.96